A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis
Terminated · Phase 2 · NCT05911841
Conditions: Atopic Dermatitis
At a glance
- Research payments reported, 2025
- $159,550
- U.S. investigators named
- 10
- Sites paid
- 11
- Planned or actual enrollment
- 234
About the trial
- Sponsor
- Eli Lilly and Company
- Tested
- LY3454738 (drug), Placebo (drug)
- Dates
- Started 2023-06-21; completion 2025-03-14
- Results posted
- Yes
The main purpose of this study is to describe the efficacy and safety of LY3454738 in adult participants with moderate-to-severe atopic dermatitis (AD).
From ClinicalTrials.gov, last updated 2025-12-02. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Eli Lilly and Company reported $159,550 in research payments for this study in 2025 (20 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Sandra M. Johnson, MD Dermatology · Fort Smith, AR
- Howard L. Sofen, M.D. Dermatology · Los Angeles, CA
- Malisa Agard, M.D. Internal Medicine · Orlando, FL
- Jerome R. Obed, DO Dermatology · Fort Lauderdale, FL
- Lee S. Clore JR., M.D. Allergy & Immunology · Owensboro, KY
- Ali Moiin, MD Dermatology · Troy, MI
- Phoebe Rich, MD Specialist · Portland, OR
- Stephen M. Schleicher, M.D. Dermatology · Sugarloaf, PA
- Mark S. Lee, M.D. Dermatology · San Antonio, TX
- Patricia C. Lee, M.D. Dermatology · Webster, TX
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Conquest Research LLC $36,773
- Encore Medical Research, LLC $32,945
- Oregon Dermatology and Research Center $22,038
- Progressive Clinical Research $20,823
- Revival Research Institute LLC $13,815
- Allergy and Asthma Specialists Psc $10,126
- Best Skin Research LLC $8,750
- Dermatology Research Associates Inc $6,411
- Center for Clinical Studies LTD LLP $4,820
- Johnson Dermatology PLLC $2,646
- Capital Clinical Research Center PLLC $403
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.